Scarica l'app Stockscreener
216.65
0.85%
-1.85
Pre-mercato:
214.15
-2.50
-1.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BIIB Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$218.50
Aprire:
$216.47
Volume 24 ore:
808.89K
Relative Volume:
0.70
Capitalizzazione di mercato:
$32.01B
Reddito:
$9.60B
Utile/perdita netta:
$1.37B
Rapporto P/E:
23.25
EPS:
9.3182
Flusso di cassa netto:
$2.32B
1 W Prestazione:
-0.67%
1M Prestazione:
+6.79%
6M Prestazione:
+12.94%
1 anno Prestazione:
+63.86%
Intervallo 1D:
$213.58
$218.89
Intervallo di 1 settimana:
$213.58
$222.85
Portata 52W:
$133.53
$222.85
Biogen Inc Stock (BIIB) Company Profile
Nome
Biogen Inc
Settore
Industria
Telefono
(781) 464-2000
Indirizzo
225 BINNEY STREET, CAMBRIDGE, MA
Compare BIIB vs LLY, JNJ, ABBV, MRK, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIIB
Biogen Inc
|
216.65 | 31.67B | 9.60B | 1.37B | 2.32B | 9.3182 |
LLY
Lilly Eli Co
|
1,156.73 | 1.11T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
265.85 | 644.33B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
256.42 | 462.68B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
147.76 | 367.58B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
152.06 | 296.97B | 54.66B | 13.58B | 16.05B | 7.0171 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-22 | Aggiornamento | UBS | Neutral → Buy |
| 2026-04-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-04-14 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2026-02-20 | Iniziato | Barclays | Equal Weight |
| 2026-02-09 | Reiterato | H.C. Wainwright | Buy |
| 2026-01-07 | Ripresa | UBS | Neutral |
| 2025-12-10 | Downgrade | HSBC Securities | Hold → Reduce |
| 2025-11-06 | Aggiornamento | Stifel | Hold → Buy |
| 2025-09-25 | Iniziato | Jefferies | Buy |
| 2025-07-21 | Ripresa | Truist | Hold |
| 2025-04-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-04 | Downgrade | Argus | Buy → Hold |
| 2025-02-11 | Iniziato | Bernstein | Mkt Perform |
| 2025-01-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-16 | Downgrade | Stifel | Buy → Hold |
| 2024-12-10 | Ripresa | BofA Securities | Neutral |
| 2024-12-09 | Downgrade | Jefferies | Buy → Hold |
| 2024-11-18 | Downgrade | Needham | Buy → Hold |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-31 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-10 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-14 | Reiterato | Needham | Buy |
| 2024-02-14 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-01-24 | Downgrade | UBS | Buy → Neutral |
| 2023-12-20 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-12-07 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Outperform |
| 2023-07-24 | Reiterato | UBS | Buy |
| 2023-05-01 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-04-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-26 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-10-13 | Aggiornamento | Stifel | Hold → Buy |
| 2022-10-07 | Aggiornamento | Argus | Hold → Buy |
| 2022-09-28 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-09-28 | Aggiornamento | Mizuho | Neutral → Buy |
| 2022-09-28 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-08 | Downgrade | Stifel | Buy → Hold |
| 2022-03-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-04 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-04 | Reiterato | Barclays | Equal Weight |
| 2022-02-04 | Reiterato | BofA Securities | Neutral |
| 2022-02-04 | Reiterato | Cowen | Outperform |
| 2022-02-04 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-04 | Reiterato | Needham | Buy |
| 2022-02-04 | Reiterato | Oppenheimer | Outperform |
| 2022-02-04 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-04 | Reiterato | Robert W. Baird | Neutral |
| 2022-02-04 | Reiterato | Wedbush | Neutral |
| 2022-02-04 | Reiterato | Wells Fargo | Equal Weight |
| 2022-02-04 | Reiterato | Wolfe Research | Peer Perform |
| 2022-01-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-01-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Ripresa | Raymond James | Mkt Perform |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Outperform |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2021-06-18 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-06-14 | Reiterato | Truist | Buy |
| 2021-06-11 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2021-06-10 | Aggiornamento | UBS | Neutral → Buy |
| 2021-06-08 | Aggiornamento | Atlantic Equities | Underweight → Neutral |
| 2021-06-08 | Reiterato | Barclays | Equal Weight |
| 2021-06-08 | Aggiornamento | Citigroup | Sell → Neutral |
| 2021-06-08 | Reiterato | H.C. Wainwright | Buy |
| 2021-06-08 | Reiterato | Jefferies | Buy |
| 2021-06-08 | Reiterato | Morgan Stanley | Overweight |
| 2021-06-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2021-06-08 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2021-06-08 | Reiterato | Stifel | Buy |
| 2021-06-08 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2021-06-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-06-07 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-06-07 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2021-02-05 | Downgrade | DZ Bank | Buy → Hold |
| 2021-01-29 | Aggiornamento | Stifel | Hold → Buy |
| 2020-11-10 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-11-09 | Downgrade | Atlantic Equities | Neutral → Underweight |
| 2020-11-09 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-11-09 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-11-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-11-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-11-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-07-27 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2020-06-22 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-06-22 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2020-06-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-04-23 | Downgrade | Citigroup | Neutral → Sell |
| 2020-04-23 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-27 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-12-13 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2019-12-02 | Downgrade | Robert W. Baird | Neutral → Underperform |
Mostra tutto
Biogen Inc Borsa (BIIB) Ultime notizie
Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial - TipRanks
Biogen Inc. (NASDAQ:BIIB) Healthcare Momentum Draws Fresh Market Attention - Kalkine Media
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders - Yahoo Finance
OVERSEA CHINESE BANKING Corp Ltd Purchases Shares of 18,867 Biogen Inc. $BIIB - MarketBeat
Wealthfront Advisers LLC Acquires Shares of 16,529 Biogen Inc. $BIIB - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Acquires Shares of 13,000 Biogen Inc. $BIIB - MarketBeat
66,365 Shares in Biogen Inc. $BIIB Bought by Danske Bank A S - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Biogen Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Biogen (BIIB) And The Alzheimer’s Narrative As Valuation Stays In Focus - simplywall.st
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month? - TradingView
Impax Global Women's Leadership Fund's Biogen Inc(BIIB) Holding History - GuruFocus
Is Wall Street Bullish or Bearish on Biogen Stock? - Barchart.com
Meeder Advisory Services Inc. Acquires Shares of 4,608 Biogen Inc. $BIIB - MarketBeat
Edmond DE Rothschild Holding S.A. Makes New Investment in Biogen Inc. $BIIB - MarketBeat
Biogen Inc (BIIB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BIIB Stock Price Prediction 2025-2026 | Biogen Inc Forecast - 24/7 Wall St.
Biogen Inc (BIIB) Stock Up 4.2% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch
Biogen (NASDAQ:BIIB) Sets New 1-Year HighTime to Buy? - MarketBeat
Biogen (BIIB) Stock Surges to 52-Week Peak After BlackRock’s $3.4B Investment - Blockonomi
Biogen stock hits 52-week high at 219.94 USD - Investing.com
Biogen stock holds above $212 as Leqembi momentum grows - ad-hoc-news.de
Mitsubishi UFJ Asset Management Co. Ltd. Takes $77.53 Million Position in Biogen Inc. $BIIB - MarketBeat
Deutsche Bank AG Takes $193.16 Million Position in Biogen Inc. $BIIB - MarketBeat
15,985,736 Shares in Biogen Inc. $BIIB Bought by BlackRock Inc. - MarketBeat
Biogen Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Biogen stock holds near $209 after Q2 beat - AD HOC NEWS
Pallas Capital Advisors LLC Acquires Shares of 12,859 Biogen Inc. $BIIB - MarketBeat
K.J. Harrison & Partners Inc Makes New $2.16 Million Investment in Biogen Inc. $BIIB - MarketBeat
Plato Investment Management Ltd Invests $1.49 Million in Biogen Inc. $BIIB - MarketBeat
Lantheus Wins FDA Approval for Alzheimer's Tau PET Imaging Agent - finance.biggo.com
Biogen (NASDAQ:BIIB) Shows Strong Technical Breakout Setup With Perfect Trend Rating - ChartMill
Biogen stock holds steady as new Alzheimer’s imaging agent reshapes dementia diagnostics - Ad-hoc-news.de
Nippon Life Global Investors Americas Inc. Buys New Stake in Biogen Inc. $BIIB - MarketBeat
Biogen Inc. (BIIB) Investor Outlook: Exploring A Promising 13.23% Potential Upside - DirectorsTalk Interviews
Focus Partners Advisor Solutions LLC Buys New Position in Biogen Inc. $BIIB - MarketBeat
NewEdge Advisors LLC Trims Position in Biogen Inc. $BIIB - MarketBeat
Biogen Inc.: Target Price Consensus and Analysts Recommendations | 0R1B | US09062X1037 - marketscreener.com
Biogen Stock (BIIB) Opinions on Analyst Upgrade and Acquisition - Quiver Quantitative
Biogen (BIIB) Edges Higher to $210.65 as Biotech Sentiment FirmsQuality ETF - vinanet.vn
Wolfe Research Issues Rare Double Upgrade for Biogen and AbbVie, Setting $300 Targets - finance.biggo.com
BIIB Upgraded by Wolfe Research -- Price Target Raised to $300 - GuruFocus
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation - Yahoo Finance
Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300 - marketscreener.com
Handelsbanken Fonder AB Has $20.14 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat
BIIB Q2 2026 Earnings: Strong EPS Surprise of 19.75% Lifts SharesAnnual Report - vinanet.vn
Formation Bio taps Biogen, Pfizer alum to tackle R&D’s ‘boring middle’ - Pharma Voice
Insight Wealth Strategies LLC Has $7.20 Million Holdings in Biogen Inc. $BIIB - MarketBeat
Biogen Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Biogen Inc Azioni (BIIB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biogen Inc Azioni (BIIB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Minor Lloyd | Director |
Aug 04 '26 |
Sale |
200.96 |
593 |
119,169 |
2,689 |
1.79%
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):